Skip to main content
See every side of every news story
Published • loading... • Updated

Novartis Targets 5% Annual Sales Growth Through 2031 Despite Patent Expirations

The Swiss drugmaker lifted peak sales targets for three medicines to $18 billion combined as it seeks to offset looming patent losses and recent trial setbacks.

  • On Thursday, Drugmaker Novartis set a 5% annual sales growth target through 2031, aiming to offset patent expiries and recover from recent late-stage clinical study setbacks.
  • The company raised its peak sales forecast for Kesimpta, Scemblix, and Leqvio to $18 billion combined, up from $14 billion, to counter competition facing older blockbusters.
  • Peak sales for Kisqali are forecast at $10 billion, with increased expectations of $8 billion for Kesimpta and $5 billion each for Scemblix and Leqvio.
  • Following a $2.2 billion writedown this year, shares fell 2.4% in Switzerland as investors scrutinized CEO Vas Narasimhan's dealmaking strategy.
  • CEO Vas Narasimhan expects growth beyond 2031 to come from internal medicines, with M&A contributions remaining consistent with the $63 billion spent on business development over the last decade.
Insights by Ground AI

17 Articles

Lean Right

Novartis predicted a steady growth in sales until 2031, highlighting the momentum generated by medicines already present in the market and by future launches; the company also stated that the drugs in its development portfolio will help sustain long-term growth. Exclusive material for subscribers. To have full access, access the link of the material and register.

·Rio de Janeiro, Brazil
Read Full Article
ReutersReuters
+2 Reposted by 2 other sources
Center

Novartis targets 5% annual sales growth through 2031

·London, United Kingdom
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources are Center
63% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

pressreach.com broke the news on Thursday, November 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal